Tech

October 12, 2012

NASA signs agreement to develop nasal spray for motion sickness

NASA’s Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With

precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

“NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas,” said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

 




All of this week's top headlines to your email every Friday.


 
 

 
NASA photograph by Carla Thomas

NASA, FAA, industry conduct initial sense-and-avoid test

NASA photograph by Carla Thomas NASA is using the remotely piloted Ikhana in the UAS-NAS project, one of the nation’s most important research efforts for improving safety and reducing technical barriers and operational challe...
 
 
nasa-spinoff

NASA Spinoff 2015 features space technology making life better on Earth

https://www.youtube.com/watch?feature=player_embedded&v=oWCWwEv_LcI&x-yt-ts=1421782837&x-yt-cl=84359240 NASA technologies are being used to locate underground water in some of the driest places on the Earth, buil...
 
 

NASA, Microsoft collaboration will allow scientists to ‘work on Mars’

NASA and Microsoft have teamed up to develop software called OnSight, a new technology that will enable scientists to work virtually on Mars using wearable technology called Microsoft HoloLens. Developed by NASA’s Jet Propulsion Laboratory in Pasadena, Calif., OnSight will give scientists a means to plan and, along with the Mars Curiosity rover, conduct science...
 

 
NASA JPL image

NASA analysis: 11 trillion gallons to replenish California drought losses

NASA JPL image NASA satellite data reveal the severity of California’s drought on water resources across the state. This map shows the trend in water storage between September 2011 and September 2014. It will take about 11 tr...
 
 
NASA photograph by George Hale

NASA’s IceBridge Antarctic campaign wraps up

NASA photograph by George Hale A view from an IceBridge survey flight Nov. 3, 2014, showing a cloud’s shadow on crevassed Antarctic ice. NASA’s Operation IceBridge recently completed its 2014 Antarctic campaign, marking the...
 
 

NASA’s 2014 HS3 hurricane mission investigated four tropical cyclones

NASA photograph NASA’s Global Hawk takes off into the sunset after mission wrap-up at NASA Wallops and heads back to NASA Armstrong. NASA’s Hurricane and Severe Storms Sentinel, or HS3, mission investigated four tropical cyclones in the 2014 Atlantic Ocean hurricane season: Cristobal, Dolly, Edouard and Gonzalo. The storms affected land areas in the Atlantic...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>